Trials / Completed
CompletedNCT02667938
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
A Multicenter, Randomized, Double-blind, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 510 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to evaluate efficacy and safety of HCP1301 capsule in patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
Detailed description
A multicenter, randomized, double-blind, phase 3 clinical trial to evaluate the efficacy and safety of HCP1303 capsule
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCP1303 capsule 5/0.2mg | |
| DRUG | HCP1303 capsule 5/0.4mg | |
| DRUG | HGP1201 | |
| DRUG | HCP1303 capsule 5/0.2mg placebo | |
| DRUG | HCP1303 capsule 5/0.4mg placebo | |
| DRUG | HGP1201 placebo |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-01-01
- Completion
- 2016-05-01
- First posted
- 2016-01-29
- Last updated
- 2016-10-13
Source: ClinicalTrials.gov record NCT02667938. Inclusion in this directory is not an endorsement.